Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid for childhood CMT1A
jRCTs031190109Active, not recruiting
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT1A). Primary endpoint: CMT score. Started Oct 2019; status: active, not recruiting.
02
Drugs
ascorbic acid
03
Conditions
Charcot-Marie-Tooth disease type 1A (CMT1A)
Beyond the preview
Go deeper on jRCTs031190109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190109.